Cobalt‐57 bleomycin for imaging head and neck tumors

James M. Woolfenden, David S. Alberts, Jack N. Hall, Dennis D. Patton

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Cobalt‐57 bleomycin imaging was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82%); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18%) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt‐57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt‐57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.

Original languageEnglish (US)
Pages (from-to)1652-1657
Number of pages6
JournalCancer
Volume43
Issue number5
DOIs
StatePublished - May 1979

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cobalt‐57 bleomycin for imaging head and neck tumors'. Together they form a unique fingerprint.

  • Cite this